Cross-sectional design and protocol for Artificial Intelligence Ready and Equitable Atlas for Diabetes Insights (AI-READI)

医学 社会心理的 老年学 人口 公共卫生 糖尿病 环境卫生 精神科 护理部 内分泌学
作者
Cynthia Owsley,Dawn S Matthies,Gerald McGwin,Jeffrey C. Edberg,Sally L. Baxter,Linda M. Zangwill,Julia P. Owen,Cecilia S. Lee
出处
期刊:BMJ Open [BMJ]
卷期号:15 (2): e097449-e097449 被引量:1
标识
DOI:10.1136/bmjopen-2024-097449
摘要

Introduction Artificial Intelligence Ready and Equitable for Diabetes Insights (AI-READI) is a data collection project on type 2 diabetes mellitus (T2DM) to facilitate the widespread use of artificial intelligence and machine learning (AI/ML) approaches to study salutogenesis (transitioning from T2DM to health resilience). The fundamental rationale for promoting health resilience in T2DM stems from its high prevalence of 10.5% of the world’s adult population and its contribution to many adverse health events. Methods AI-READI is a cross-sectional study whose target enrollment is 4000 people aged 40 and older, triple-balanced by self-reported race/ethnicity (Asian, black, Hispanic, white), T2DM (no diabetes, pre-diabetes and lifestyle-controlled diabetes, diabetes treated with oral medications or non-insulin injections and insulin-controlled diabetes) and biological sex (male, female) (Clinicaltrials.org approval number STUDY00016228). Data are collected in a multivariable protocol containing over 10 domains, including vitals, retinal imaging, electrocardiogram, cognitive function, continuous glucose monitoring, physical activity, home air quality, blood and urine collection for laboratory testing and psychosocial variables including social determinants of health. There are three study sites: Birmingham, Alabama; San Diego, California; and Seattle, Washington. Ethics and dissemination AI-READI aims to establish standards, best practices and guidelines for collection, preparation and sharing of the data for the purposes of AI/ML, including guidance from bioethicists. Following Findable, Accessible, Interoperable, Reusable principles, AI-READI can be viewed as a model for future efforts to develop other medical/health data sets targeted for AI/ML. AI-READI opens the door for novel insights in understanding T2DM salutogenesis. The AI-READI Consortium are disseminating the principles and processes of designing and implementing the AI-READI data set through publications. Those who download and use AI-READI data are encouraged to publish their results in the scientific literature.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
老的火龙果的应助被周芷卉采纳,获得10
2秒前
卷卷发布了新的文献求助10
2秒前
2秒前
齐婷婷发布了新的文献求助10
2秒前
3秒前
3秒前
4秒前
4秒前
wxy完成签到,获得积分10
4秒前
LLL完成签到,获得积分10
4秒前
6秒前
虎虎生威发布了新的文献求助10
6秒前
Mr.egg完成签到,获得积分10
6秒前
希淇发布了新的文献求助10
7秒前
紫烨完成签到,获得积分10
7秒前
李爱国的应助被如意的冰双采纳,获得10
7秒前
8秒前
dzz发布了新的文献求助10
8秒前
小泽66689完成签到,获得积分10
9秒前
牧青发布了新的文献求助150
9秒前
sunshine发布了新的文献求助10
9秒前
若枫发布了新的文献求助10
10秒前
wanglx发布了新的文献求助10
10秒前
贝木木完成签到,获得积分10
10秒前
三木完成签到,获得积分10
11秒前
研友_VZG7GZ的应助被mmccc1采纳,获得10
11秒前
木_Q完成签到,获得积分10
11秒前
黄瓜子拌高粱醋完成签到 ,获得积分10
11秒前
东方完成签到,获得积分10
12秒前
安心欢愉完成签到,获得积分10
13秒前
小泽66689发布了新的文献求助10
14秒前
岳无涯完成签到 ,获得积分10
14秒前
15秒前
aajhajkahna的应助被Abstract采纳,获得10
15秒前
15秒前
16秒前
16秒前
17秒前
加把劲骑士完成签到,获得积分10
17秒前
orixero的应助被舒适夏真采纳,获得10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
自動車の空力技術 800
Organizational Behavior 510
Management and the Arts 510
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
Die Religion in Geschichte und Gegenwart (RGG), 4. Auflage, Band 7: R–S 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7789922
求助须知:如何正确求助?哪些是违规求助? 9327473
关于积分的说明 20418530
捐赠科研通 7379351
什么是DOI,文献DOI怎么找? 3322938
关于科研通互助平台的介绍 2470856
邀请新用户注册赠送积分活动 2339796